Julia P. Gregory
Chief Financial Officer, Lexicon Pharmaceuticals.
Companies
- Biohaven PharmaceuticalsBoard member Sep 30, 2022 to now1
- Nurix (United States)Board member Jul 23, 2020 to now2
- Biohaven Pharmaceutical Holding Co Ltd.Board member Aug 4, 2017 to Oct 3, 20223
- CONTRAFECT CorpChief executive officer Jul 28, 2014 to Feb 17, 20164
- Lexicon PharmaceuticalsChief financial officer Jan 5, 2006 to Feb 11, 20085
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Biohaven Pharmaceuticals BHVN25,665 shares6$276.7K at $10.78Oct 25, 2022
Nurix (United States) NRIX10,750 shares7$268.2K at $24.95Sep 17, 2025- Biohaven Pharmaceutical Holding Co Ltd.0 shares8Dec 20, 2021
As of each latest filing. The line shows shares held over time.
Recent filings
- Sep 17, 2025Exercised options 10,750 shares at $1.86 of Nurix (United States)7
- Oct 25, 2022Bought 9,523 shares at $10.50 of Biohaven Pharmaceuticals6
- Oct 3, 2022Shares withheld for tax 11,975 shares at $7.50 of Biohaven Pharmaceuticals9
- Oct 3, 2022Exercised options 9,000 shares at $3.06 of Biohaven Pharmaceuticals9
- Oct 3, 2022Exercised options 9,000 shares at $2.33 of Biohaven Pharmaceuticals9
- Oct 3, 2022Exercised options 5,998 shares at $3.56 of Biohaven Pharmaceuticals9
- Oct 3, 2022Exercised options 4,119 shares at $4.84 of Biohaven Pharmaceuticals9
- Dec 20, 2021Sold 12,000 shares at $125.00 of Biohaven Pharmaceutical Holding Co Ltd.8
- Dec 20, 2021Exercised options 12,000 shares at $23.63 of Biohaven Pharmaceutical Holding Co Ltd.8
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2SEC EDGARNurix (United States), Board member
- 3
- 4
- 5
- 6
- 7
- 8
- 9SEC EDGARForm 4 filed Oct 5, 2022